Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CTS CORP Prospectus 2005

Jan 14, 2005

32121_prs_2005-01-14_2946b895-29ac-4782-8aeb-bf8d78a147ef.zip

Prospectus

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

424B3 1 c91199b3e424b3.htm PROSPECTUS SUPPLEMENT e424b3 PAGEBREAK

Filed Pursuant to Rule 424(b)(3) File Number 333-117826

Prospectus Supplement No. 3 dated January 14, 2005 (To Prospectus dated August 20, 2004)

CTS Corporation

2.125% Convertible Senior Subordinated Notes due 2024 and the Common Stock Issuable Upon Conversion of the Notes

This Prospectus Supplement No. 3 supplements information contained in the Prospectus dated August 20, 2004, as supplemented, covering resale by selling securityholders of our 2.125% Convertible Senior Subordinated Notes due 2024 and shares of our common stock issuable upon conversion of the notes. This Prospectus Supplement No. 3 is not complete without, and may not be delivered or utilized except in connection with, the Prospectus, including any amendments or supplements thereto. The terms of the notes are set forth in the Prospectus. Our common stock is traded on the New York Stock Exchange under the symbol “CTS.”

See “Risk Factors” beginning on page 11 of the Prospectus to read about factors you should consider before purchasing the notes or our common stock.

Neither the Securities and Exchange Commission not any state securities commission has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus supplement. Any representation to the contrary is a criminal offense.

For more information, please see the Prospectus as amended by the Prospectus Supplements.

The date of this Prospectus Supplement No. 3 is January 14, 2005.

PAGEBREAK

The information in the table appearing under the caption “Selling Securityholders” beginning on page 64 of the Prospectus is amended by adding the information below:

Aggregate — Principal Amount Percentage Common Stock Common — Stock
of Notes that of Notes Owned Prior to Registered
Name may be Sold(1) Outstanding Conversion Hereby(1)(2)
UBS AG London F/B/O HFS (3) $ 4,000,000 6.67 — 266,667

| (1) | Amounts indicated may be in excess of the total amount registered due to sales or transfers
exempt from the registration requirements of the Securities Act since the date upon which the
selling securityholders provided to us the information regarding their notes. |
| --- | --- |
| (2) | Assumes conversion of all of the holder’s notes at a conversion rate of 66.6667 shares of
common stock per $1,000 principal amount at maturity of the notes. This conversion rate will
be subject to adjustment as described under “Description of Notes — Conversion Rights” in the
Prospectus. As a result, the amount of common stock issuable upon conversion of the notes may
increase or decrease in the future. |
| (3) | Adrian Doyle has sole voting and dispositive power over the registrable securities of this
selling securityholder. |

Information concerning the selling securityholders may change from time to time. Any such changed information or information about other selling security holders will be set forth in one or more prospectus supplements, if required.